The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy
Last updated on April 2022Recruitment
- Recruitment Status
- Recruiting
Inclusion Criteria
- Older than 20 years old
- Plan to undergo cervical surgery for myelopathy
- Signed informed consent of patient or legal guardian
- ...
- Older than 20 years old
- Plan to undergo cervical surgery for myelopathy
- Signed informed consent of patient or legal guardian
- Compressive cervical myelopathy, confirmed by MRI, including C1-C2 instability, ossification of posterior longitudinal ligament
- JOA score less than 15 points
Exclusion Criteria
- severe pain from other disease
- severe cardiovascular, pulmonary, renal disease or distress, brain pathology
- Infection or malignancy
- ...
- severe pain from other disease
- severe cardiovascular, pulmonary, renal disease or distress, brain pathology
- Infection or malignancy
- patient cannot follow study protocol, for any reason
- any drug to cause bleeding tendency
- any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study
- Pregnancy or expected to be pregnant or breast feeding
- any related coagulopathy
- Taking Limaprost before surgery
Summary
- Conditions
- Cervical Myelopathy
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- Older than 20 years old
- Plan to undergo cervical surgery for myelopathy
- Signed informed consent of patient or legal guardian
- ...
- Older than 20 years old
- Plan to undergo cervical surgery for myelopathy
- Signed informed consent of patient or legal guardian
- Compressive cervical myelopathy, confirmed by MRI, including C1-C2 instability, ossification of posterior longitudinal ligament
- JOA score less than 15 points
Exclusion Criteria
- severe pain from other disease
- severe cardiovascular, pulmonary, renal disease or distress, brain pathology
- Infection or malignancy
- ...
- severe pain from other disease
- severe cardiovascular, pulmonary, renal disease or distress, brain pathology
- Infection or malignancy
- patient cannot follow study protocol, for any reason
- any drug to cause bleeding tendency
- any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study
- Pregnancy or expected to be pregnant or breast feeding
- any related coagulopathy
- Taking Limaprost before surgery
Tracking Information
- NCT #
- NCT02125981
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jin S. Yeom Seoul National University Bundang Hospital
- Jin S. Yeom Seoul National University Bundang Hospital
Get Well Soon